National Institutes of Health: all 11,571 studies

Page 42 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Development Of Neuroimaging Methods To Assess The Neurobiology Of AddictionCompletedNCT02535702Not applicable
• Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus ErythematosusCompletedNCT02535689Phase 1
• Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung CancerCompletedNCT02535325Phase 1
• Sputum Pharmacokinetics of TB Drugs and Bacterial Drug ResistanceCompletedNCT02534727
• Behavioral Economics Framingham Incentive Trial (BE FIT)CompletedNCT02531763Not applicable
• Phase 1 Study of dmLT ID Vaccination in Healthy AdultsCompletedNCT02531685Phase 1
• Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 InfectionTerminatedNCT02527460Phase 1
• Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15)CompletedNCT02527447
• Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell LymphomaActive, not recruitingNCT02520791Phase 1
• Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT02520778Phase 1
• Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT02520609
• Registry for Asthma Characterization and Recruitment 2CompletedNCT02513264
• Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...CompletedNCT02511054Phase 1
• Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of GlycosylationTerminatedNCT02511041Phase 1
• In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superparamagnetic Iron Oxide Nanoparticle, on 7 Tesla Magnetic Resonance ImagingCompletedNCT02511028Phase 1
• Hereditary Parkinson s Disease Natural History ProtocolCompletedNCT02511015
• Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult SubjectsCompletedNCT02508376Phase 1
• Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian ChildrenCompletedNCT02504918
• Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor ProcessingCompletedNCT02504905Early Phase 1
• Natural History of Multiple Sclerosis and Its MimickersCompletedNCT02504840
• Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung CancerActive, not recruitingNCT02503722Phase 1
• Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT02503709Phase 1
• Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based TherapyCompletedNCT02502890
• Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase InhibitorActive, not recruitingNCT02496663Phase 1
• Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsActive, not recruitingNCT02496208Phase 1
• In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic MelanomaWithdrawnNCT02489266Phase 1
• Are Genetic Counselors Screening for Adolescent Suicide Risk?CompletedNCT02486120
• Respiratory Syncytial Virus Human Challenge in Healthy Adult VolunteersCompletedNCT02484417Phase 1
• Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...Active, not recruitingNCT02484404Phase 1/2
• Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast CancerTerminatedNCT02474173Phase 1
• Rapid Acquisition of Pre- and Post-Incident Disaster DataWithdrawnNCT02473770
• Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge StudiesCompletedNCT02473224Phase 1
• Study of Exposure to Chemicals in Consumer ProductsCompletedNCT02471365
• Effect of Fasting on the Asthma InflammasomeCompletedNCT02471300
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
• Safety and PK of MBX-400 (Cyclopropavir) in Normal VolunteersCompletedNCT02454699Phase 1
• Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast CancerActive, not recruitingNCT02453620Phase 1
• Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)CompletedNCT02450838Phase 1
• Epi-Genetic Modulators of Fear Extinction in Alcohol DependenceCompletedNCT02438969
• Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2CompletedNCT02433652Phase 1
• Ebola Virus Disease Survivors: Clinical and Immunologic Follow-upCompletedNCT02431923
• Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected AdultsCompletedNCT02431767Phase 1
• dbGaP Protocol: Genetic Variants Associated With Pentalogy of CantrellCompletedNCT02430376
• VR High Tech Pain Control Burn Wound CareCompletedNCT02427659Not applicable
• Oral Guanabenz for Multiple SclerosisTerminatedNCT02423083Phase 1
• Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid TumorsCompletedNCT02423057Phase 1
• Spatial Context and Fear LearningCompletedNCT02423044
• Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial DistressCompletedNCT02423031
• Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048CompletedNCT02419456Phase 1
• NIAID Clinical Center Genomics Opportunity ProtocolCompletedNCT02417766
• Feasibility Study of Deep Brain Recordings for Learning and MemoryWithdrawnNCT02417727
• Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsCompletedNCT02415153Phase 1
• Neurocognitive Driving Rehabilitation in Virtual Environments (NeuroDRIVE) as an Adjunctive Intervention for Traumatic Brain InjuryCompletedNCT02411227Phase 2
• VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy AdultsCompletedNCT02408913Phase 1
• Muscle Ultrasound Measures as Biomarkers of Upper Motor Neuron FunctionCompletedNCT02408900
• Inhaled Nanosilver StudyWithdrawnNCT02408874
• MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform NeurofibromasActive, not recruitingNCT02407405Phase 2
• Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy VolunteersCompletedNCT02404870Phase 1
• Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver FibrosisCompletedNCT02400216
• FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine TherapyActive, not recruitingNCT02398773Phase 2
• Study to Assess Potential Interactions Between Intravenous Cocaine and Oral LorcaserinCompletedNCT02393599Phase 1
• Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy AdultsCompletedNCT02392325Phase 1
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid CancerWithdrawnNCT02390739Phase 1/2
• Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult VolunteersWithdrawnNCT02389192Phase 1
• Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation TherapyActive, not recruitingNCT02381561Phase 1
• Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid LeukemiaTerminatedNCT02381548Phase 1
• Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and CisplatinCompletedNCT02381535Phase 1
• Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid TumorsCompletedNCT02379416Phase 1
• Effects of Tart Cherry and Aroniaberry Supplementation on Endothelial Function and Cardiovascular Measures in Healthy Older Adults: Interactions With Genotype and ProteomeWithdrawnNCT02379403
• NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in TuberculosisCompletedNCT02371681Phase 2
• The Role of Phosphodiesterase Inhibitors in Incretin SecretionCompletedNCT02363335Phase 1
• Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02363309
• Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)CompletedNCT02363296Not applicable
• Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal NeuropathyCompletedNCT02362438Phase 1
• Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or MedulloblastomaActive, not recruitingNCT02359565Phase 1
• Safety and Pharmacokinetics of Intravaginal Rings Containing Vicriviroc (MK-4176) and/or MK-2048CompletedNCT02356302Phase 1
• Psychological Outcomes in Isolated GnRH DeficiencyTerminatedNCT02356172
• Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in UgandaCompletedNCT02354404Phase 1
• Genitourinary and Pharyngeal Pharmacokinetics of SolithromycinCompletedNCT02348424Phase 1
• Cross Calibration of Two Dual Energy Densitometers and Comparison of Regional Adipose Tissue Measurements by iDXA and MRICompletedNCT02346474
• Physiological and Psychosomatic Effects of Exposure to MRI Scanning EnvironmentWithdrawnNCT02339883
• A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced MelanomaActive, not recruitingNCT02339571Phase 2/3
• DoD-NCI TRICARE Feasibility StudyCompletedNCT02339025
• Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious DiseasesCompletedNCT02338986
• Phase 1 Trial of Inactivated West Nile Virus VaccineCompletedNCT02337868Phase 1
• A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy AdultsCompletedNCT02337855Phase 1
• Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)WithdrawnNCT02337842Phase 1
• Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and MaliCompletedNCT02334462Phase 1
• Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in ThailandCompletedNCT02332733Phase 2
• Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple SclerosisCompletedNCT02330965
• Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care TreatmentCompletedNCT02326857
• Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry ProtocolCompletedNCT02322177
• Psychophysical Correlates of Pain Reduction by Topical Analgesic CompoundsCompletedNCT02322164
• Pharmacokinetics of Granulocyte Colony Stimulating Factor in the Breast Milk of Volunteer Peripheral Blood Stem Cell DonorCompletedNCT02322151
• Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal TumorsCompletedNCT02319018Phase 1
• Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy AdultsCompletedNCT02317900Phase 1
• Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced CancerCompletedNCT02317874Phase 1
• Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close OtherCompletedNCT02317380
• Self-Affirmation: Construct ValidityCompletedNCT02317367
• People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical TrialCompletedNCT02317354

← National Institutes of Health overview and focus areas